您当前的位置:
首页 >
文章列表页 >
Enlightenment of Immunological Progress in 2022 on Treatment of COVID-19 with Traditional Chinese Medicine
更新时间:2024-07-12
    • Enlightenment of Immunological Progress in 2022 on Treatment of COVID-19 with Traditional Chinese Medicine

    • Significant progress has been made in the field of immunology in 2022, covering innate immunity, inflammasomes, T cell immunity, B cell function, immune exhaustion, and the immunological mechanisms of COVID-19. Interdisciplinary collaboration and technological integration have driven the development of immunology, with high-throughput sequencing, full spectrum flow cytometry, gene editing, protein engineering, AI combined with biotechnology providing strong support for in-depth research on immune response characteristics, patterns, underlying mechanisms, and targets. The research results provide new ideas for developing effective treatment methods, vaccines, and drugs. However, the variation of novel coronavirus, the characteristics of immune escape, the effectiveness and safety of immunotherapy for tumor and autoimmune diseases still need to be further studied.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 16, Pages: 229-239(2024)
    • DOI:10.13422/j.cnki.syfjx.20231337    

      CLC: R2-0;R33;G353.11;R593
    • Received:10 July 2023

      Published Online:12 September 2023

      Published:20 August 2024

    移动端阅览

  • YU Zeyue,SUN Jianhui,HAO Liyu,et al.Enlightenment of Immunological Progress in 2022 on Treatment of COVID-19 with Traditional Chinese Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):229-239. DOI: 10.13422/j.cnki.syfjx.20231337.

  •  
  •  

0

Views

41

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Antibacterial and Immune Regulating Efficacies of Xiaoer Qingwen Jiere Granules
Invasion and Metastasis Inhibition of Lung Cancer by Traditional Chinese Medicine: A Review
Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma Ameliorates Myocardial Ischemia-reperfusion Injury in Rats via FUNDC1-dependent Mitophagy
Visual Analysis of Literature Research on Compatibility of Bitter and Pungent Medicinals in Traditional Chinese Medicine

Related Author

CHEN Xi
Yang Qing
LI Qi
CHEN Ying
KAN Xiao-xi
HUANG He-fei
LI Yu-jie
WANG Ya-jie

Related Institution

The Second Clinical Medical College, Henan University of Chinese Medicine
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
0